Spyre Therapeutics said on Monday its experimental bowel disease drug met the main goal of significantly reducing disease severity in a mid-stage trial.
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/spyre-says-bowel-disease-drug-cuts-inflammation-mid-stage-2026a1000k4e?src=rss
Author :
Publish date : 2026-06-15 12:28:00
Copyright for syndicated content belongs to the linked Source.